PK and PD of Sequential Multiple Ascending, Repeat Doses of Oral CXA-10 in Healthy Obese Male Subjects
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The main purpose of this trial is to demonstrate the safety, tolerability and
pharmacokinetics (PK) of CXA-10 and its metabolite(s) administered as multiple ascending oral
doses over 14 days to healthy obese male volunteers.